EN
HI
Syncom Formulations (India) Share Price
SYNCOMF
22.130.04 (0.18%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 20 Nov, 2026, Syncom Formulations (India) stock price is ₹22.13. During the trading session, the stock has moved between an intraday low of ₹21.90 and an intraday high of ₹22.72. Over the last 52 weeks, Syncom Formulations (India) has traded between ₹10.21 and ₹27.49.
The stock has recorded a trading volume of 84,52,450 shares,. Its Average Traded Price (ATP) is ₹22.32, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 100 @ ₹22.13.
Syncom Formulations (India) has an upper circuit limit of ₹26.50 and a lower circuit limit of ₹17.68. The total value traded stands at ₹18.87 CR, and the delivery percentage for the day is 23.41%.
The stock is currently traded with a market lot size of 1. Syncom Formulations (India) also offers a dividend yield of 0.45%.
Syncom Formulations (India) Share Price Chart
Syncom Formulations (India) Share Key Metrics
Volume
84.52 L
Market Cap
2076.46 CR
LTQ@LTP
100@22.13
ATP
22.32
Var Margin
24.6 %
Circuit Range
17.68-26.5
Delivery %
23.41 %
Value
18.87 CR
ASM/GSM
No
Market Lot
1
Syncom Formulations (India) Resistance and Support
Pivot 21.98
Resistance
First Resistance
22.45
Second Resistance
22.82
Third Resistance
23.29
Support
First Support
21.61
Second Support
21.14
Third Support
20.77
Syncom Formulations (India) Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
50.57%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
2.23%
Domestic Institutional Investors
-0.01%
Retail
47.2%
Others
0.01%
Total Promoters
MAR '26
50.57%
JUN '26
50.57%
SEP '26
50.57%
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-13 | Quarterly Results and Other business matters |
| 2026-08-11 | Quarterly Results |
| 2026-05-22 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-23 | 2026-09-23 | View More |
Syncom Formulations (India) News
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Outcome for Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026, Pursuant To Regulation 33(3) Of The SEBI (LODR) Regulations, 2015.
Syncom Formulations reported its financial results for the quarter ended September 2026, with cons. revenue at ₹142.14 crores and net profit rising 60.5% YoY to ₹26.65 crores. Standalone net profit also grew to ₹25.40 crores.
Nov 13 2026 16:46:28
Syncom Formulations India Ltd-$ - 524470 - Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations, 2015 Read With SEBI (PIT) Regulations, 2015 Regarding Intimation Of Holding The 3/2026-27 Board Meeting Scheduled To Be Held On Friday, 13Th Day Of November, 2026
Syncom Formulations board of directors will meet on 13 Nov 2026 to consider the financial results for Q2 FY27. The meeting will be held at the corporate office in Indore.
Nov 04 2026 15:51:17
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Vaishali Agrawal | Company Secretary & Compliance Officer |
| Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
Sakar Healthcare Ltd.
1028.60
52.40 (5.37%)
Indoco Remedies Ltd.
233.20
0.12 (0.05%)
Sai Parenteral's Ltd.
485.25
-10.15 (2.05%)
Panacea Biotec Ltd.
348.45
-4.40 (1.25%)
Windlas Biotech Ltd.
970.05
-12.40 (1.26%)
Beta Drugs Ltd.
1649.80
-114.40 (6.48%)
Hester Biosciences Ltd.
2325.70
-26.40 (1.12%)
Venus Remedies Ltd.
1519.20
17.60 (1.17%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 22.13 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 21.72. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 4.42. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 40.43 & 2.58 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 2076.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 27.49 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SYNCOMF
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC